Effect of intrauterine injection of human gonadotropin (HCG) on the outcome of embryo transfer cycles

The effect of intrauterine injection of human gonadotropin (HCG) on the outcome of embryo transfer cycles in women

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200213046475N1

Enrollment

300

Registered

2020-03-03

Start date

2020-03-05

Completion date

Unknown

Last updated

2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary infertility. Female infertility

Interventions

Intervention 1: Intervention group: 40 µl of tissue culture medium containing 500 units of HCG by intrauterine injection. Intervention 2: Control group: Embryo transfer without intrauterine injection

Eligibility

Sex/Gender

Female

Age

No minimum to 40 Years

Inclusion criteria

Inclusion criteria: Women with primary infertility who have had at least one fetal transfer At least have one Grade A or B frozen embryo

Exclusion criteria

Exclusion criteria: Age over 40 years BMI over 30 kg/m2 Infertility with severe male cause such as azoospermia Uterine myoma or history of myomectomy Endometriosis Grade 3 and 4 Hydrosalpingitis The duration of freezing of the fetus more than 2 years

Design outcomes

Secondary

Measure	Time frame
Abortion rate. Timepoint: Before the 20th week of pregnancy. Method of measurement: Observation.	—

Primary

Measure	Time frame
Pregnancy rate. Timepoint: 2 weeks after embryo transfer. Method of measurement: Sonography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahshid Karimi

Tehran University of Medical Sciences

s_khazaeii@yahoo.com+98 21 6649 2271

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026